SBIR/STTR Research Award

MEASURING DRUG ABUSE RISK IN EAPS & WORKPLACE SETTINGS

Award identifier ebf45b280f56b346c1aaa2962ce3cc514c1d612e9aeb0af2d527e539e8091b86Awarding agency Department of Health and Human Services

Award amount

$49,217

Program and phase

SBIR · Phase I

Award year

1991

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
INTERSYSTEMS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

THIS STUDY WILL DEVELOP AND PILOT TEST AN ASSESSMENT SCALE TO MEASURE DRUG ABUSE RISK AMONG AMERICAN WORKERS WITHIN EMPLOYEE ASSISTANCE PROGRAM (EAP) AND WORKPLACE SETTINGS. THE LONG-TERM OBJECTIVE OF THIS RESEARCH IS TO PRODUCE A RELIABLE, VALID, AND USEFUL MEASURE OF DRUG ABUSE RISK FOR WORKPLACE DIAGNOSTIC AND REFERRAL PURPOSES. SEQUENTIALLY, THE STUDY WILL ADDRESS THREE AIMS. THE FIRST AIM IS TO DEVELOP A SCALE FOR EAPS AND WORKPLACE SETTINGS TO ASSESS PHYSICAL, PSYCHOLOGICAL, AND SOCIAL DOMAINS AMONG WORKERS WHO HAVE DRUG PROBLEMS AND TO DIRECT TREATMENT REFERRALS. BY ADAPTING ITEMS AND SUBSCALES FROM OTHER MEASURES AND ENGAGING THE SERVICES OF EXPERT PANELS, THE FIRST AIM WILL YIELD A ROUGH DRAFT OF THE ASSESSMENT SCALE. THE SECOND AIMIS TO PSYCHOMETRICALLY TEST THE SCALE FOR RELIABILITY AMONG A SAMPLE OF WORKERS. IN COLLABORATION WITH WORK SITES THAT PROVIDE STRATIFIED SAMPLES OF EMPLOYEES, PSYCHOMETRIC TESTING WILL INVOLVE TEST-RETEST PROCEDURES. THE THIRD AIM IS TO DETERMINE THE ASSESSMENT SCALE'S ACCEPTABILITY AND RESPONSIVENESS FOR ASSESSING WORKER PROBLEMS WITH DRUGS AND FOR MAKING APPROPRIATE REFERRALS. ALSO IN COLLABORATION WITH EAP AND WORKPLACE SETTINGS, TESTING WITHIN THE STUDY'S THIRD AIM WILL INVOLVE PROCESS EVALUATION FEEDBACK AND COMPARATIVE ANALYSES WITH EXTANT ASSESSMENT MEASURES. THIS STUDY WILL DEVELOP AND PILOT TEST AN ASSESSMENT SCALE TO MEASURE DRUG ABUSE RISK AMONG AMERICAN WORKERS WITHIN EMPLOYEE ASSISTANCE PROGRAM (EAP) AND WORKPLACE SETTINGS. THE LONG-TERM OBJECTIVE OF THIS RESEARCH IS TO PRODUCE A RELIABLE, VALID, AND USEFUL MEASURE OF DRUG ABUSE RISK FOR WORKPLACE DIAGNOSTIC AND REFERRAL PURPOSES. SEQUENTIALLY, THE STUDY WILL ADDRESS THREE AIMS. THE FIRST AIM IS TO DEVELOP A SCALE FOR EAPS AND WORKPLACE SETTINGS TO ASSESS PHYSICAL, PSYCHOLOGICAL, AND SOCIAL DOMAINS AMONG WORKERS WHO HAVE DRUG PROBLEMS AND TO DIRECT TREATMENT REFERRALS. BY ADAPTING ITEMS AND SUBSCALES FROM OTHER MEASURES AND ENGAGING THE SERVICES OF EXPERT PANELS, THE FIRST AIM WILL YIELD A ROUGH DRAFT OF THE ASSESSMENT SCALE. THE SECOND AIMIS TO PSYCHOMETRICALLY TEST THE SCALE FOR RELIABILITY AMONG A SAMPLE OF WORKERS. IN COLLABORATION WITH WORK SITES THAT PROVIDE STRATIFIED SAMPLES OF EMPLOYEES, PSYCHOMETRIC TESTING WILL INVOLVE TEST-RETEST PROCEDURES. THE THIRD AIM IS TO DETERMINE THE ASSESSMENT SCALE'S ACCEPTABILITY AND RESPONSIVENESS FOR ASSESSING WORKER PROBLEMS WITH DRUGS AND FOR MAKING APPROPRIATE REFERRALS. ALSO IN COLLABORATION WITH EAP AND WORKPLACE SETTINGS, TESTING WITHIN THE STUDY'S THIRD AIM WILL INVOLVE PROCESS EVALUATION FEEDBACK AND COMPARATIVE ANALYSES WITH EXTANT ASSESSMENT MEASURES.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.